Thi Bich Uyen Le

521 total citations
11 papers, 336 citations indexed

About

Thi Bich Uyen Le is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Thi Bich Uyen Le has authored 11 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Hepatology. Recurrent topics in Thi Bich Uyen Le's work include Fibroblast Growth Factor Research (8 papers), Kruppel-like factors research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Thi Bich Uyen Le is often cited by papers focused on Fibroblast Growth Factor Research (8 papers), Kruppel-like factors research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Thi Bich Uyen Le collaborates with scholars based in Singapore, United States and Switzerland. Thi Bich Uyen Le's co-authors include Dorothy French, Richard A.D. Carano, Ronald E. Ferrando, Jason Ross, Avi Ashkenazi, Alain D’Souza, Qing Jiang, Rama Pai, Luc Desnoyers and Iman Mohtashemi and has published in prestigious journals such as Oncogene, International Journal of Molecular Sciences and Oncotarget.

In The Last Decade

Thi Bich Uyen Le

11 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thi Bich Uyen Le Singapore	9	268	64	63	43	31	11	336
Hajrah Khawaja United Kingdom	7	147 0.5×	54 0.8×	115 1.8×	73 1.7×	41 1.3×	8	272
Xuetao Shi China	9	174 0.6×	147 2.3×	45 0.7×	38 0.9×	16 0.5×	13	292
Shenglan Huang China	11	150 0.6×	95 1.5×	69 1.1×	60 1.4×	43 1.4×	23	295
Mengxian Tu China	6	116 0.4×	84 1.3×	46 0.7×	37 0.9×	29 0.9×	8	225
Chuanchao He China	12	295 1.1×	166 2.6×	71 1.1×	58 1.3×	27 0.9×	21	411
Liguang Yang China	8	218 0.8×	111 1.7×	47 0.7×	48 1.1×	30 1.0×	14	324
Paola Francica Switzerland	10	158 0.6×	47 0.7×	124 2.0×	39 0.9×	21 0.7×	14	249
Yoshimoto Nomura Japan	7	195 0.7×	103 1.6×	104 1.7×	92 2.1×	17 0.5×	12	315
Darlan Conterno Minussi United States	8	119 0.4×	120 1.9×	55 0.9×	24 0.6×	18 0.6×	11	223

Countries citing papers authored by Thi Bich Uyen Le

Since Specialization

Citations

This map shows the geographic impact of Thi Bich Uyen Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thi Bich Uyen Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thi Bich Uyen Le more than expected).

Fields of papers citing papers by Thi Bich Uyen Le

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thi Bich Uyen Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thi Bich Uyen Le. The network helps show where Thi Bich Uyen Le may publish in the future.

Co-authorship network of co-authors of Thi Bich Uyen Le

This figure shows the co-authorship network connecting the top 25 collaborators of Thi Bich Uyen Le. A scholar is included among the top collaborators of Thi Bich Uyen Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thi Bich Uyen Le. Thi Bich Uyen Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Le, Thi Bich Uyen, et al.. (2021). Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor. Journal of Cancer Research and Clinical Oncology. 147(10). 2955–2968. 10 indexed citations

Le, Thi Bich Uyen, et al.. (2021). Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease. International Journal of Molecular Sciences. 22(8). 3918–3918. 14 indexed citations

Le, Thi Bich Uyen, et al.. (2021). Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma. Hepatology International. 15(5). 1236–1246. 10 indexed citations

Le, Thi Bich Uyen, et al.. (2021). [Effect of miR-23b on the malignant phenotype and the sensitivity of lenvatinib in human hepatocellular carcinoma cells].. PubMed. 29(5). 433–438. 2 indexed citations

Huynh, Hung, Thi Bich Uyen Le, Huai-Xiang Hao, et al.. (2020). FGF401 and vinorelbine synergistically mediate antitumor activity and vascular normalization in FGF19-dependent hepatocellular carcinoma. Experimental & Molecular Medicine. 52(11). 1857–1868. 19 indexed citations

Tran, Anh, Tong San Koh, Thi Bich Uyen Le, et al.. (2020). Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Imaging Biomarker for Vascular Normalization Effect of Infigratinib in High-FGFR-Expressing Hepatocellular Carcinoma Xenografts. Molecular Imaging and Biology. 23(1). 70–83. 4 indexed citations

Le, Thi Bich Uyen, et al.. (2020). Ribociclib enhances infigratinib‐induced cancer cell differentiation and delays resistance in FGFR‐driven hepatocellular carcinoma. Liver International. 41(3). 608–620. 15 indexed citations

Le, Thi Bich Uyen, et al.. (2020). Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 21(24). 9405–9405. 13 indexed citations

Lu, Hengyu, Chen Liu, Hung Huynh, et al.. (2020). Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR. Oncotarget. 11(3). 265–281. 27 indexed citations

10.

Yeoh, Kheng Wei, et al.. (2020). Vinorelbine Augments Radiotherapy in Hepatocellular Carcinoma. Cancers. 12(4). 872–872. 8 indexed citations

11.

Desnoyers, Luc, Rama Pai, Ronald E. Ferrando, et al.. (2007). Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene. 27(1). 85–97. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact